Oxovanadium(IV) cyclam and bicyclam complexes: potential CXCR4 receptor antagonists. - Wikidata - awgldk - TriplyDB

Oxovanadium(IV) cyclam and bicyclam complexes: potential CXCR4 receptor antagonists.

Oxovanadium(IV) cyclam and bicyclam complexes: potential CXCR4 receptor antagonists.

http://www.wikidata.org/entity/Q33639946

about

The potentiality of vanadium in medicinal applications.Perspectives for vanadium in health issues.Zinc(II) complexes of constrained antiviral macrocycles.The future of/for vanadium.Harnessing CXCR4 antagonists in stem cell mobilization, HIV infection, ischemic diseases, and oncology.

P2860

Q38050178-78F9837B-D047-4F46-9D55-4DF57E0A567B Q38742665-F07FBAC1-DDEA-46A6-BEF7-83C8E3EA91B4 Q39371008-DA84AF93-5021-44EB-B0E7-121785917AFA Q39438047-CCFA8428-C8CA-44ED-9116-09F9D3253B7D Q40109819-C08EF5FA-49A3-4A81-B2B6-3F71CDAE7588

P2860

Oxovanadium(IV) cyclam and bicyclam complexes: potential CXCR4 receptor antagonists.

http://www.wikidata.org/entity/Q33639946

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Oxovanadium(IV) cyclam and bicyclam complexes: potential CXCR4 receptor antagonists.

@ast

Oxovanadium(IV) cyclam and bicyclam complexes: potential CXCR4 receptor antagonists.

@en

type

label

Oxovanadium(IV) cyclam and bicyclam complexes: potential CXCR4 receptor antagonists.

@ast

Oxovanadium(IV) cyclam and bicyclam complexes: potential CXCR4 receptor antagonists.

@en

prefLabel

Oxovanadium(IV) cyclam and bicyclam complexes: potential CXCR4 receptor antagonists.

@ast

Oxovanadium(IV) cyclam and bicyclam complexes: potential CXCR4 receptor antagonists.

@en

P1433

Q33639946-20BDD5B3-C870-4F56-947D-1446F9CBC6D8

P1476

Q33639946-C6A34214-EBB0-4D02-AD56-0CC8929A8A0C

P2093

Q33639946-03D439A1-6129-439F-97DB-C346F3AB6731

Q33639946-14B20855-A945-43C5-BFB7-2890B0A0C249

Q33639946-505E476F-AE7F-46F7-BEC5-EC12AAF59E1F

Q33639946-5669407D-5F9A-46DD-9A43-D60589CCF6C7

Q33639946-757929CE-9268-4E1F-B166-DA772928C4F9

Q33639946-C24F000A-2283-473F-BDAC-7C66131BA498

P2860

Q33639946-0BAC7553-C79E-4866-A9F5-CDB2B18A5E73

Q33639946-115DA2EC-CB3D-4555-A3C2-DDAAC34559FE

Q33639946-1E24CD76-5B8B-4F83-9936-A887BDE1FA00

Q33639946-258869A9-0CED-41A9-9636-873C8D236CEC

Q33639946-2D6D4CE8-A5D0-4781-8C22-B9D24B1E5EBD

Q33639946-452586E2-F751-41DF-B655-D98D8A4AB8B6

Q33639946-4CC04998-3B25-4432-AEE4-6DAAE6729611

Q33639946-5FBB8DEA-6C32-4E02-8063-F3B449C22FAC

Q33639946-7FB3153D-8980-4F8D-A107-476592EF997A

Q33639946-93490002-C421-4EEE-A0DA-427FB32FCB56

P304

Q33639946-FA9D2E82-3CFC-440B-926D-E2EF94E82259

P31

Q33639946-CA48BA07-A005-46BE-9C6B-8B946C32C2F2

P356

Q33639946-28B5102F-86DA-4C18-971C-4CBB8D9F4E03

P407

Q33639946-EADE52D1-B23E-4F15-BDB4-E39BC3398DF7

P433

Q33639946-29748A0B-4B91-414C-8FB3-4871711A0B12

P478

Q33639946-E5EEC703-429F-454E-BD33-E4185E74BEED

P50

Q33639946-070B0E08-08C4-4D9E-8F1E-3F712FA3A96D

Q33639946-8116BE35-8AB2-4DBB-960C-0D7FE080A672

Q33639946-9297536B-73E0-4C2D-9EF1-AB94FE52DBFD

Q33639946-A45BE43B-8DC4-412F-9C3E-5D62664FE4D0

Q33639946-BE6E5997-436E-4C2F-95D9-12933123FE04

P577

Q33639946-FDBC1D67-DBFB-452E-9975-AE3154B5DC96

P5875

Q33639946-1EFB8CCC-F87E-4096-B876-CD92398D5147

P698

Q33639946-543330AA-181F-4761-AE0F-FAFE0AE146C1

P932

Q33639946-107BBB29-79BA-46C2-B677-620B4D094259

P356

P1433

Inorganic Chemistry

P1476

Oxovanadium(IV) cyclam and bicyclam complexes: potential CXCR4 receptor antagonists.

@en

P2093

Allison Ross

http://www.w3.org/2001/XMLSchema#string

Anna Collins

http://www.w3.org/2001/XMLSchema#string

Danielle Covelli

http://www.w3.org/2001/XMLSchema#string

Laura Budd

http://www.w3.org/2001/XMLSchema#string

Peter J Sadler

http://www.w3.org/2001/XMLSchema#string

Simon Parsons

http://www.w3.org/2001/XMLSchema#string

P2860

The analysis of the human high affinity IgE receptor Fc epsilon Ri alpha from multiple crystal forms

The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus

Activity of different bicyclam derivatives against human immunodeficiency virus depends on their interaction with the CXCR4 chemokine receptor

T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV

ATHENA, ARTEMIS, HEPHAESTUS: data analysis for X-ray absorption spectroscopy using IFEFFIT.

Protein recognition of macrocycles: binding of anti-HIV metallocyclams to lysozyme.

Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV.

Naphthalene sulfonate polymers with CD4-blocking and anti-human immunodeficiency virus type 1 activities.

The bicyclam AMD3100 story.

The chemistry and biochemistry of vanadium and the biological activities exerted by vanadium compounds.

P304

1122-1132

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1021/IC9020614

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

49

http://www.w3.org/2001/XMLSchema#string

P50

Dinesh C. Soares

Pierre Kennepohl

Christophe Pannecouque

P577

2010-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40811480

http://www.w3.org/2001/XMLSchema#string

P698

20039648

http://www.w3.org/2001/XMLSchema#string

P932

2818883

http://www.w3.org/2001/XMLSchema#string